You have 4 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BAT®

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dermatitis, Atopic Trial (Monoclonal antibody BAT6026, sodium chloride injection)

Not yet recruiting
  • Dermatitis, Atopic
  • Monoclonal antibody BAT6026
  • sodium chloride injection
  • (no location specified)
Oct 19, 2023

Fibromyalgia Trial in Gainesville (Breathing and Attention Training (BAT), Breathing Control)

Recruiting
  • Fibromyalgia
  • Breathing and Attention Training (BAT)
  • Breathing Control
  • Gainesville, Florida
    University of Florida
Mar 23, 2023

Advanced Solid Tumor Trial in Zhengzhou, Linyi (BAT4706 Injection, BAT1308 Injection)

Not yet recruiting
  • Advanced Solid Tumor
  • BAT4706 Injection
  • BAT1308 Injection
  • Zhengzhou, Henan, China
  • +2 more
Nov 14, 2023

Healthy Male Subjects Trial (Recombinant Humanized Anti-PD-1 Monoclonal Antibody Solution for Injection, Pembrolizumab

Not yet recruiting
  • Healthy Male Subjects
  • Recombinant Humanized Anti-PD-1 Monoclonal Antibody Solution for Injection
  • Pembrolizumab injection
  • (no location specified)
Oct 30, 2023

Factors Affecting BAT Activation in PET/CT

Not yet recruiting
  • Factors Affecting BAT Activation in PET/CT
  • PET/CT
  • (no location specified)
Oct 9, 2022

Healthy Men Trial in Hefei (BAT1706 Injection)

Not yet recruiting
  • Healthy Men
  • BAT1706 Injection
  • Hefei, Anhui, China
    The Second Affiliated Hospital of Anhui Medical University
May 9, 2023

Healthy Men Trial in Hefei (BAT1806 prefilled subcutaneous injection/RoActemra® (from EU))

Not yet recruiting
  • Healthy Men
  • BAT1806 prefilled subcutaneous injection/RoActemra® (from EU)
  • Hefei, Anhui, China
    The Second Affiliated Hospital of Anhui Medical University
Jul 27, 2023

Obesity Trial in Nice (Sampling)

Not yet recruiting
  • Obesity
  • Sampling
  • Nice, France
    Hôpital Archet 2
Apr 25, 2023

Advanced or Metastatic Solid Tumors Trial in Guangzhou (BAT8010 for Injection)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • BAT8010 for Injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Apr 27, 2023

Advanced Solid Tumors Trial in Guangzhou (BAT8007 for injection)

Recruiting
  • Advanced Solid Tumors
  • BAT8007 for injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 26, 2023

Advanced Malignant Tumor Trial in Guangzhou (BAT7104 injection)

Recruiting
  • Advanced Malignant Tumor
  • BAT7104 injection
  • Guangzhou, Guangdong, China
    Li Zhang
Mar 1, 2023

Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)

Not yet recruiting
  • Essential Thrombocythemia
  • (no location specified)
Oct 6, 2023

Cervical Cancer Trial in Wuhan (Recombinant humanized anti-PD-1 mAb injection, Cisplatin, Bevacizumab Injection)

Not yet recruiting
  • Cervical Cancer
  • Recombinant humanized anti-PD-1 monoclonal antibody injection
  • +4 more
  • Wuhan, Hubei, China
    Tongji Hospital affiliated to Tongji Medical College of Huazhong
Nov 3, 2023

Psoriatic Arthritis Trial (BAT2506 injection, Simponi® (EU commercially available product), Simponi® (US commercially available

Recruiting
  • Psoriatic Arthritis
  • BAT2506 injection
  • +2 more
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Jan 11, 2023

Plaque Psoriasis Trial (BAT2306, EU-approved Cosentyx)

Recruiting
  • Plaque Psoriasis
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital of Zhejiang University School of
Jan 9, 2023

Advanced Solid Tumors Trial (BAT8008 for Injection)

Not yet recruiting
  • Advanced Solid Tumors
  • BAT8008 for Injection
  • (no location specified)
Nov 9, 2022

Aging Trial in Orlando (Maximal oxygen consumption (V02 max), Brown adipose tissue (BAT) imaging, Muscle function testing)

Active, not recruiting
  • Aging
  • Maximal oxygen consumption (V02 max)
  • +2 more
  • Orlando, Florida
    Translational Research Institute for Metabolism and Diabetes
Nov 16, 2022

Severe Asthma Trial in Jilin (Mepolizumab Injection (BAT2606 Injection), Mepolizumab Injection (EU-licensed Nucala), Mepolizumab

Recruiting
  • Severe Asthma
  • Mepolizumab Injection (BAT2606 Injection)
  • +2 more
  • Jilin, China
    The First Hospital of Jilin University
Oct 8, 2022

Locally Advanced/Metastatic Solid Tumours Trial (BAT8009 for Injection)

Recruiting
  • Locally Advanced/Metastatic Solid Tumours
  • BAT8009 for Injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 25, 2022

Neovascular (Wet) Age-related Macular Degeneration Trial (BAT5906 injection, Lucentis)

Not yet recruiting
  • Neovascular (Wet) Age-related Macular Degeneration
  • (no location specified)
Jun 26, 2022

Plaque Psoriasis Trial in Hangzhou (BAT2206, Stelara (EU-sourced))

Active, not recruiting
  • Plaque Psoriasis
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital of Zhejiang University School of
Aug 18, 2022

Botulism Trial (A minimum of one 5 mL serum sample (up to three per enrolled subject) will be collected.)

Enrolling by invitation
  • Botulism
  • Blood sample collection
  • (no location specified)
Jan 30, 2023

Resistant Hypertension Trial in Worldwide (BAT, Placebo)

Active, not recruiting
  • Resistant Hypertension
  • BAT
  • Placebo
  • Odense, Denmark
  • +4 more
Mar 14, 2022

Relapsed/Refractory Acute Myeloid Leukemia Trial in Beijing

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
  • Best-Available Therapy(BAT) Regimen
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Oct 10, 2023

Advanced Solid Tumors Trial in Changchun (BAT8006 for Injection)

Recruiting
  • Advanced Solid Tumors
  • BAT8006 for Injection
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Jul 26, 2022